Clinical Trials Logo
  1. Home
  2. Eye Diseases
  3. NCT04404803
  4. Details
NCT04404803 Clinical Trial

Motivations and Barriers to Participating in Ophthalmology Research Projects

Eye Diseases Clinical Trial

Official title:
Motivations and Barriers to Participating in Ophthalmology Research Projects

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04404803
Other study ID # B00366
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 21, 2019
Est. completion date January 2024

Study information
Verified date April 2023
Source Manchester University NHS Foundation Trust
Contact Monika Cien
Phone 01617011765
Email monika.cien@mft.nhs.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this project is to understand the reasons why patients agree / disagree to take part in ophthalmology research. This will be done by asking participants to complete a Research Questionnaire.

Recruitment information / eligibility
Status Recruiting
Enrollment 1500
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - Over 16 years old - Willing to participate by completing the questionnaire - Must be able to speak and read English Exclusion Criteria: - Under 16 years of age - Not willing to complete the questionnaire

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• questionnaire
Patients will be asked to complete a questionnaire about the reasons why they agree / decline to take part in research.

Locations
Country Name City State
United Kingdom Monika Cien Manchester

Sponsors (1)
Lead Sponsor Collaborator
Manchester University NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Assessment of motivations to participating in ophthalmology research. Questionnaire 5 years
Primary Assessment of barriers in participating in ophthalmology research Questionnaire 5 years
See also
  Status Clinical Trial Phase
Recruiting NCT05414994 - Assessment of the Ocular Microbiome in Health and Disease
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Completed NCT02811692 - Study for Collection of Aflibercept Data in Routine Practice
Recruiting NCT06045299 - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia Phase 3
Recruiting NCT01521065 - An Open-label Study to Evaluate the Clinical and Economic Benefits of I-Ray in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration Phase 2
Completed NCT04799704 - Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.
Recruiting NCT05876689 - Swept Source OCT Imaging With the DREAM VG-OCT
Active, not recruiting NCT04123626 - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene Phase 1/Phase 2
Recruiting NCT04150432 - Correlation Between Exhaled Propofol Concentration With Plasma Concentration in Children N/A
Not yet recruiting NCT05550740 - Repeated Low-Level Red-Light Therapy for Shortening Axial Length N/A
Completed NCT02332343 - Sparing of the Fovea in Geographic Atrophy Progression N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Terminated NCT01225146 - Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) Phase 1
Completed NCT00333203 - Next Generation Ophthalmic Irrigating Solution Posterior Segment Study Phase 3
Not yet recruiting NCT05565547 - Multimodal Equipment for Teleophthalmology Assessment (META)
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Recruiting NCT06112340 - A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) Phase 2/Phase 3
Recruiting NCT06451172 - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis Early Phase 1
Completed NCT05211089 - Manual Versus Automated Choroidal Thickness Measurements Using Swept-source Anterior Segment OCT
Not yet recruiting NCT06070467 - Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases